Loading...
Loading...
India's indomethacin imports from GUYANA total $633 across 1 shipments from 1 foreign suppliers. DR BALWANT SINGHS HOSPITAL INC leads with $633 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include PANDEY DRUG HOUSE. This corridor reflects India's pharmaceutical import demand for indomethacin — a concentrated sourcing relationship with select suppliers from GUYANA.

DR BALWANT SINGHS HOSPITAL INC is the leading Indomethacin supplier from GUYANA to India, with import value of $633 across 1 shipments. The top 5 suppliers — DR BALWANT SINGHS HOSPITAL INC — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR BALWANT SINGHS HOSPITAL INC | $633 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PANDEY DRUG HOUSE | $633 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Indomethacin suppliers from GUYANA to India include DR BALWANT SINGHS HOSPITAL INC. The leading supplier is DR BALWANT SINGHS HOSPITAL INC with import value of $633 USD across 1 shipments. India imported Indomethacin worth $633 USD from GUYANA in total across 1 shipments.
India imported Indomethacin worth $633 USD from GUYANA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Indomethacin sourced from GUYANA include PANDEY DRUG HOUSE. The largest buyer is PANDEY DRUG HOUSE with $633 in imports across 1 shipments.
The total value of Indomethacin imports from GUYANA to India is $633 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists